We are a biotechnology company developing novel therapeutics to treat diseases caused by protein misfolding, with an initial focus on lysosomal storage disorders (“LSDs”), including rare genetic diseases and neurological disorders. We use our exclusively in-licensed proprietary platform, Site-Directed Enzyme Enhancement Therapy (“SEE-Tx”), to discover novel allosteric sites on misfolded proteins and identify proprietary small […]

We intend to focus our search on businesses that may provide significant opportunities for attractive investor returns. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although we expect to focus on a target in an industry where we believe our management team and founders’ […]

The Duckhorn Portfolio is the premier scaled producer of luxury wines in North America. We have delighted millions of consumers with authentic, high-quality, approachable wines for over four decades. Founded by our namesake Dan and Margaret Duckhorn in 1976, we began by pioneering Merlot wines in Napa Valley and now champion a curated and comprehensive […]

(Note:  IPOScoop has “No Call” on this offering. This is NOT a traditional IPO. This is a “step-up” or “uplift” IPO of ADS on the NASDAQ by a company whose ordinary shares trade on the Tel Aviv Stock Exchange Ltd. (TASE) under the symbol “MEAT.” From the prospectus: “This is our initial public offering of […]

Our focus will be predominantly within the technology industry and specifically on: (i) cloud infrastructure software; (ii) software as a service (SaaS) consumer and enterprise applications; and (iii) security software. Sreekanth Ravi has been chairman of our board of directors and our CEO since August 2020. Mr. Ravi has over 29 years of experience working in software and the broader technology […]

We intend to capitalize on sector transformative events by focusing on companies that use or facilitate disruptive, differentiated technology to build, enable, service or manage businesses or infrastructure undergoing transformation. In particular, we intend to focus on private and public companies as potential initial business combination targets in end markets — software, technology enabled services, communications, […]

Jay Markowitz, Jeff Leiden, Hemant Taneja, Robert Nelsen, Catherine Friedman, Jennifer Schneider, Kris Engskov, Jason Doren, Mark McDonnell and Evan Sotiriou have established Revolution Healthcare Acquisition Corp., a newly formed blank check company. Our mission is to partner with leading businesses at the intersection of health care, life sciences and technology to redesign health care […]

(Note: This is the 10th blank check company created by Alec Gores, the founder, chairman and CEO of The Gores Group, a global investment firm.) Our management team is led by Alec Gores of The Gores Group.  We intend to focus our search for a target technology business in the consumer internet, enterprise software, fintech, […]

(Note: This is the ninth blank check company organized under the leadership of Alec Gores, the founder, chairman and CEO of The Gores Group, a global investment firm.) Our team is led by Alec Gores, our chairman, and Ted Fike and Justin Wilson, our co-CEOs. Mr. Fike and Mr. Wilson are senior managing directors at the […]

Wilbur L. Ross, Jr., the U.S. secretary of commerce in the Trump Administration, formed this blank check company with Stephen J. Toy and Nadim Z. Qureshi, the co-founders and managing partners of BroadPeak Global, a private equity firm. (Incorporated in the Cayman Islands.) From the prospectus: ” We intend to focus our efforts in identifying a […]